Product analysis: the device remains implanted, therefore no product analysis can be performed.
conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.
If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that approximately two years, six months, and thirteen days following the implant of this transcatheter bioprosthetic pulmonary valve into a stenotic 17 millimeter (mm) homograft, the valve was balloon dilated using a 22 millimeter (mm) non-medtronic balloon.
The reason for dilation was not able to be confirmed, however it was suspected to be performed due to increased right ventricular (rv) pressure and increased rv-pulmonary artery (pa) pressures.
Approximately nine years and fifteen days following the valve implant, the patient presented with moderate stenosis of the valve due to type ll (nordmeyer classification) stent fractures, right ventricular dilatation and dysfunction, a peak to peak gradient of approximately 50 mmhg, and right ventricular systolic pressures of 75 mmhg which is 2/3 of the systemic pressure.
No treatment was performed.
No additional adverse patient effects were reported.
.
|